Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY and BRIAN ARTHURS

Core Laboratories Scores RS Rating Upgrade; Hits Key Benchmark

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Core Laboratories cleared that benchmark Monday, with a jump from 66 to 88 Monday. Over 100 years of market history reveals that the market's biggest winners typically have an RS Rating north of 80 as they launch their biggest climbs.

When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

IBD's proprietary RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks matches up against other publicly traded companies.

See How IBD Helps You Make More Money In Stocks

See If Core Laboratories Can Form A Base

While CLB stock is not near an ideal buy point right now, it is worth keeping an eye on to see if it manages to form and break out of a proper base.

Core Laboratories saw both earnings and sales growth rise last quarter. Earnings-per-share increased from -33% to 0%. Revenue rose from 2% to 7%.

Core Laboratories is a leading provider of proprietary and patented reservoir description, production enhancement and reservoir management services

Core Laboratories earns the No. 25 rank among its peers in the Oil & Gas-Field Services industry group. Halliburton and RPC are also among the group's highest-rated stocks.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.